Beam Therapeutics
BEAM
BEAM
215 hedge funds and large institutions have $1.84B invested in Beam Therapeutics in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 82 increasing their positions, 66 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
35% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 54
62% less call options, than puts
Call options by funds: $14.1M | Put options by funds: $37.3M
Holders
215
Holding in Top 10
3
Calls
$14.1M
Puts
$37.3M
Top Buyers
| 1 | +$85.8M | |
| 2 | +$14.2M | |
| 3 | +$13.9M | |
| 4 |
Goldman Sachs
New York
|
+$10.3M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$10.1M |
Top Sellers
| 1 | -$35.4M | |
| 2 | -$29.1M | |
| 3 | -$17.1M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$10.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.93M |
